Dipyridamole disposition after chronic administration: effect of aspirin.

Dipyridamole disposition after chronic administration: effect of aspirin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Dipyridamole disposition after chronic administration: effect of aspirin. Abstract Text:

Dipyridamole disposition after chronic administration: effect of aspirin. Publishing Authors By Initials

For similar biochemical phenomena, metabolism, and nutrition: biochemical phenomena: protein binding research abstracts see: biochemical phenomena, metabolism, and nutrition: biochemical phenomena: protein binding research

PUBMED ID PMID:

MEDLINE DATE:

Dipyridamole disposition after chronic administration: effect of aspirin. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Thrombosis research. Supplement

VOLUME: 4

Page Numbers: 137-43

Journal Abbreviation: Thromb. Res. Suppl.

ISSN: 0049-3848

DAY: 28

MONTH: 02

YEAR: 1983

Dipyridamole disposition after chronic administration: effect of aspirin. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8309239

Dipyridamole disposition after chronic administration: effect of aspirin. Keywords Mesh Terms:

KEYWORDS: Protein Binding

MESH TERMS: metabolism

Chemical & Substance for Abstract: Dipyridamole disposition after chronic administration: effect of aspirin. Information

Substance Name: Dipyridamole

Registry Number: 58-32-2

Grant and Affiliation Information for Dipyridamole disposition after chronic administration: effect of aspirin.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Thromb Res Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Dipyridamole disposition after chronic administration: effect of aspirin Related Publications

• Antithrombotic therapy in atrial fibrillation.
• Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT).
• Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin.
• Dipyridamole disposition after chronic administration: effect of aspirin.
• Drug reimbursement policies in Canada--need for improved access to critical therapies.
• Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.
• Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
• Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.
• New oral anticoagulants in atrial fibrillation.
• Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concerns.
• Population pharmacokinetics and pharmacodynamics of rivaroxaban - an oral, direct factor xa inhibitor - in patients undergoing major orthopaedic surgery.
• SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) study.
• Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.
• Tuberculosis in Somalia.
• [Antithrombotic treatment of atrial fibrillation]